THORNWOOD, N.Y., July 15 -- Carl Zeiss MicroImaging, the Lucy Whittier Molecular and Diagnostic Core Facility at the University of California at Davis (UC Davis), and Palm Microlaser Technologies recently announced they are collaborating in research activities using Palm's laser microdissection and pressure catapulting (LMPC) technologies and UC Davis's capabilities at the core facility. Carl Zeiss MicroImaging Inc. is a provider of upright, inverted, stereo and confocal microscopes, imaging systems, high-content screening (HCS) and high-throughput screening (HTS) systems, and is the exclusive distributor for Palm MicroLaser Systems in North America.
The Lucy Whittier Molecular and Diagnostic Core Facility is an independent unit at the School of Veterinary Medicine at UC Davis that was created from a grant by a private foundation to stimulate and enhance molecular research. Palm Microlaser Technologies AG is a supplier of laser microdissection and micromanipulation systems using LMPC technology, which allows the isolation and transportation of the targeted material into a collecting device using only the force of light, eliminating contamination with unwanted adjacent tissue or mechanical contact.
Carl Zeiss and Palm will use facilities at UC Davis for information, demonstration and training on the Palm laser microdissection unit. UC Davis will use the technology for the isolation and collection of pure tissue samples to be processed with its analytical systems. Joint development of protocols and application support activities for applications of laser microdissection is another goal of the cooperative effort. Palm's research and application laboratory in Germany will also be used in the exchange.
For more information, visit: www.zeiss.com